APO RESEARCH · REPORT
Biomedical Materials
Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.
Product & engineering
Understand the product.
Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.
Selected research
Industry Research
Biomedical Materials Industry Research Report 2026
Market perspective
Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.
Global Biomedical Materials key players include Johnson & Johnson, ZimmerBiomet, Medtronic, Abbott Laboratories, etc. Global top four manufacturers hold a share about 30%.
North America is the largest market, with a share over 55%, followed by Europe, and Rest of Asia, both have a share over 25 percent.
Read the full market overview
In terms of product, Plastic Surgery is the largest segment, with a share over 20%. And in terms of application, the largest application is Treatment, followed by Health and Beauty.
Report Scope
This report quantifies the global Biomedical Materials market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Biomedical Materials.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomedical Materials Market by Company
Johnson & Johnson
ZimmerBiomet
Medtronic
Abbott Laboratories
Stryker
Boston Scientific
Smith+Nephew
B-Braun
Straumann
Danaher Corporation
Dentsply Sirona
Cook Medical
Terumo
MicroPort
Lepu Medical
Biomedical Materials Segment by Type
Orthopaedic
Cardiac Surgery
Neurosurgery
Plastic Surgery
Other
Biomedical Materials Segment by Application
Treatment
Health and Beauty
Biomedical Materials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Materials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Biomedical Materials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Orthopaedic
- Cardiac Surgery
- Neurosurgery
- Plastic Surgery
- Other
Applications
- Treatment
- Health and Beauty
Companies covered
- Johnson & Johnson
- ZimmerBiomet
- Medtronic
- Abbott Laboratories
- Stryker
- Boston Scientific
- Smith+Nephew
- B-Braun
- Straumann
- Danaher Corporation
- Dentsply Sirona
- Cook Medical
- Terumo
- MicroPort
- Lepu Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomedical Materials by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Orthopaedic
- 2.2.3 Cardiac Surgery
- 2.2.4 Neurosurgery
- 2.2.5 Plastic Surgery
- 2.2.6 Other
- 2.3 Biomedical Materials by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Treatment
- 2.3.3 Health and Beauty
- 2.4 Assumptions and Limitations
3 Biomedical Materials Breakdown Data by Type
- 3.1 Global Biomedical Materials Historic Market Size by Type (2021-2026)
- 3.2 Global Biomedical Materials Forecasted Market Size by Type (2027-2032)
4 Biomedical Materials Breakdown Data by Application
- 4.1 Global Biomedical Materials Historic Market Size by Application (2021-2026)
- 4.2 Global Biomedical Materials Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Biomedical Materials Market Perspective (2021-2032)
- 5.2 Global Biomedical Materials Growth Trends by Region
- 5.2.1 Global Biomedical Materials Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Biomedical Materials Historic Market Size by Region (2021-2026)
- 5.2.3 Biomedical Materials Forecasted Market Size by Region (2027-2032)
- 5.3 Biomedical Materials Market Dynamics
- 5.3.1 Biomedical Materials Industry Trends
- 5.3.2 Biomedical Materials Market Drivers
- 5.3.3 Biomedical Materials Market Challenges
- 5.3.4 Biomedical Materials Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Biomedical Materials Players by Revenue
- 6.1.1 Global Top Biomedical Materials Players by Revenue (2021-2026)
- 6.1.2 Global Biomedical Materials Revenue Market Share by Players (2021-2026)
- 6.2 Global Biomedical Materials Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Biomedical Materials Head Office and Area Served
- 6.4 Global Biomedical Materials Players, Product Type & Application
- 6.5 Global Biomedical Materials Manufacturers Established Date
- 6.6 Global Biomedical Materials Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Biomedical Materials Market Size (2021-2032)
- 7.2 North America Biomedical Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Biomedical Materials Market Size by Country (2021-2026)
- 7.4 North America Biomedical Materials Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Biomedical Materials Market Size (2021-2032)
- 8.2 Europe Biomedical Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Biomedical Materials Market Size by Country (2021-2026)
- 8.4 Europe Biomedical Materials Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Biomedical Materials Market Size (2021-2032)
- 9.2 Asia-Pacific Biomedical Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Biomedical Materials Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Biomedical Materials Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Biomedical Materials Market Size (2021-2032)
- 10.2 South America Biomedical Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Biomedical Materials Market Size by Country (2021-2026)
- 10.4 South America Biomedical Materials Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Biomedical Materials Market Size (2021-2032)
- 11.2 Middle East & Africa Biomedical Materials Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Biomedical Materials Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Biomedical Materials Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Information
- 12.1.2 Johnson & Johnson Business Overview
- 12.1.3 Johnson & Johnson Revenue in Biomedical Materials Business (2021-2026)
- 12.1.4 Johnson & Johnson Biomedical Materials Product Portfolio
- 12.1.5 Johnson & Johnson Recent Developments
- 12.2 ZimmerBiomet
- 12.2.1 ZimmerBiomet Company Information
- 12.2.2 ZimmerBiomet Business Overview
- 12.2.3 ZimmerBiomet Revenue in Biomedical Materials Business (2021-2026)
- 12.2.4 ZimmerBiomet Biomedical Materials Product Portfolio
- 12.2.5 ZimmerBiomet Recent Developments
- 12.3 Medtronic
- 12.3.1 Medtronic Company Information
- 12.3.2 Medtronic Business Overview
- 12.3.3 Medtronic Revenue in Biomedical Materials Business (2021-2026)
- 12.3.4 Medtronic Biomedical Materials Product Portfolio
- 12.3.5 Medtronic Recent Developments
- 12.4 Abbott Laboratories
- 12.4.1 Abbott Laboratories Company Information
- 12.4.2 Abbott Laboratories Business Overview
- 12.4.3 Abbott Laboratories Revenue in Biomedical Materials Business (2021-2026)
- 12.4.4 Abbott Laboratories Biomedical Materials Product Portfolio
- 12.4.5 Abbott Laboratories Recent Developments
- 12.5 Stryker
- 12.5.1 Stryker Company Information
- 12.5.2 Stryker Business Overview
- 12.5.3 Stryker Revenue in Biomedical Materials Business (2021-2026)
- 12.5.4 Stryker Biomedical Materials Product Portfolio
- 12.5.5 Stryker Recent Developments
- 12.6 Boston Scientific
- 12.6.1 Boston Scientific Company Information
- 12.6.2 Boston Scientific Business Overview
- 12.6.3 Boston Scientific Revenue in Biomedical Materials Business (2021-2026)
- 12.6.4 Boston Scientific Biomedical Materials Product Portfolio
- 12.6.5 Boston Scientific Recent Developments
- 12.7 Smith+Nephew
- 12.7.1 Smith+Nephew Company Information
- 12.7.2 Smith+Nephew Business Overview
- 12.7.3 Smith+Nephew Revenue in Biomedical Materials Business (2021-2026)
- 12.7.4 Smith+Nephew Biomedical Materials Product Portfolio
- 12.7.5 Smith+Nephew Recent Developments
- 12.8 B-Braun
- 12.8.1 B-Braun Company Information
- 12.8.2 B-Braun Business Overview
- 12.8.3 B-Braun Revenue in Biomedical Materials Business (2021-2026)
- 12.8.4 B-Braun Biomedical Materials Product Portfolio
- 12.8.5 B-Braun Recent Developments
- 12.9 Straumann
- 12.9.1 Straumann Company Information
- 12.9.2 Straumann Business Overview
- 12.9.3 Straumann Revenue in Biomedical Materials Business (2021-2026)
- 12.9.4 Straumann Biomedical Materials Product Portfolio
- 12.9.5 Straumann Recent Developments
- 12.10 Danaher Corporation
- 12.10.1 Danaher Corporation Company Information
- 12.10.2 Danaher Corporation Business Overview
- 12.10.3 Danaher Corporation Revenue in Biomedical Materials Business (2021-2026)
- 12.10.4 Danaher Corporation Biomedical Materials Product Portfolio
- 12.10.5 Danaher Corporation Recent Developments
- 12.11 Dentsply Sirona
- 12.11.1 Dentsply Sirona Company Information
- 12.11.2 Dentsply Sirona Business Overview
- 12.11.3 Dentsply Sirona Revenue in Biomedical Materials Business (2021-2026)
- 12.11.4 Dentsply Sirona Biomedical Materials Product Portfolio
- 12.11.5 Dentsply Sirona Recent Developments
- 12.12 Cook Medical
- 12.12.1 Cook Medical Company Information
- 12.12.2 Cook Medical Business Overview
- 12.12.3 Cook Medical Revenue in Biomedical Materials Business (2021-2026)
- 12.12.4 Cook Medical Biomedical Materials Product Portfolio
- 12.12.5 Cook Medical Recent Developments
- 12.13 Terumo
- 12.13.1 Terumo Company Information
- 12.13.2 Terumo Business Overview
- 12.13.3 Terumo Revenue in Biomedical Materials Business (2021-2026)
- 12.13.4 Terumo Biomedical Materials Product Portfolio
- 12.13.5 Terumo Recent Developments
- 12.14 MicroPort
- 12.14.1 MicroPort Company Information
- 12.14.2 MicroPort Business Overview
- 12.14.3 MicroPort Revenue in Biomedical Materials Business (2021-2026)
- 12.14.4 MicroPort Biomedical Materials Product Portfolio
- 12.14.5 MicroPort Recent Developments
- 12.15 Lepu Medical
- 12.15.1 Lepu Medical Company Information
- 12.15.2 Lepu Medical Business Overview
- 12.15.3 Lepu Medical Revenue in Biomedical Materials Business (2021-2026)
- 12.15.4 Lepu Medical Biomedical Materials Product Portfolio
- 12.15.5 Lepu Medical Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst